DALPIAZ, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 11.046
EU - Europa 3.031
AS - Asia 2.117
SA - Sud America 39
AF - Africa 8
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.252
Nazione #
US - Stati Uniti d'America 11.037
CN - Cina 1.142
UA - Ucraina 930
TR - Turchia 519
IT - Italia 484
DE - Germania 448
GB - Regno Unito 351
SG - Singapore 280
SE - Svezia 258
FI - Finlandia 202
PL - Polonia 176
FR - Francia 69
IN - India 46
HK - Hong Kong 30
CZ - Repubblica Ceca 26
BR - Brasile 22
PK - Pakistan 20
ID - Indonesia 19
NL - Olanda 17
BE - Belgio 16
IR - Iran 16
AT - Austria 14
VN - Vietnam 14
CO - Colombia 12
RU - Federazione Russa 12
CA - Canada 8
IQ - Iraq 7
JP - Giappone 7
IE - Irlanda 6
EG - Egitto 5
KR - Corea 5
RO - Romania 5
TH - Thailandia 5
AU - Australia 4
CH - Svizzera 4
HU - Ungheria 4
EU - Europa 3
GR - Grecia 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AR - Argentina 1
BG - Bulgaria 1
MN - Mongolia 1
MX - Messico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 16.252
Città #
Woodbridge 1.460
Fairfield 1.336
Jacksonville 1.010
Houston 998
Chandler 869
Ashburn 630
Ann Arbor 622
Wilmington 556
Seattle 526
Cambridge 480
Izmir 334
Nanjing 294
Princeton 226
Beijing 195
Boardman 189
Ferrara 178
Warsaw 176
Singapore 143
San Diego 116
Addison 103
Nanchang 96
Milan 90
New York 83
Shenyang 78
Hebei 73
Shanghai 71
Tianjin 51
Changsha 49
Falls Church 49
Bremen 48
Redwood City 46
San Mateo 46
Los Angeles 44
Dearborn 43
Jiaxing 35
Kunming 32
Norwalk 31
Mountain View 28
Jinan 26
Hong Kong 24
Zhengzhou 22
Helsinki 19
Philadelphia 19
Auburn Hills 18
Jakarta 18
London 18
Ningbo 18
Washington 18
Tappahannock 17
Düsseldorf 15
Olomouc 15
Verona 15
Bologna 13
Brussels 13
Indiana 13
Lanzhou 13
Orange 13
Rome 12
Guangzhou 11
Vienna 11
Hangzhou 10
Islamabad 10
Leawood 10
Augusta 9
Dong Ket 8
Guarda Veneta 8
Hyderabad 8
Redmond 8
Taizhou 8
Dallas 7
Medellín 7
Amsterdam 6
Brno 6
Changchun 6
Des Moines 6
Hefei 6
Monmouth Junction 6
Rovere Veronese 6
Ardabil 5
Bogotá 5
Gurgaon 5
Ho Chi Minh City 5
Islington 5
Paris 5
Wuhan 5
Argenta 4
Dublin 4
Haikou 4
Itajaí 4
Jaipur 4
Masi Torello 4
Modena 4
Taiyuan 4
Bolzano 3
Chicago 3
Codevigo 3
Forest City 3
Frankfurt Am Main 3
Hanover 3
Hounslow 3
Totale 12.018
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 241
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 199
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 154
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 146
Physicochemical stability of cabazitaxel and docetaxel solutions 146
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 145
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 144
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 142
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 136
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 128
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 123
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 123
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 122
Conjugation of aspirin with vitamin C: uptake and stability studies 122
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 121
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 121
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 119
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 118
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 117
Binding thermodynamics at A1 and A2A adenosine receptors 116
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 115
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 114
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 111
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 110
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 110
Conformational Aspects of Human Formyl-peptide Receptor Agonists 109
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres. 108
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 107
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 107
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 106
Progress in drug delivery to the central nervous system by the prodrug approach 106
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 106
null 106
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 105
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 104
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 103
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 103
null 103
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 103
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 102
null 101
Thermodynamics of full agonist, partial agonist and antagonist binding to wild type and mutant adenosine A1 receptors. 101
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 101
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 100
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 100
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 100
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: a thermodynamic analysis. 99
Binding thermodynamics of 5-HT(1A) receptor ligands 99
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 99
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 99
Conformational aspects of human formylpeptide receptor antagonists 98
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 97
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 96
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 96
Binding thermodynamics of adenosine A2a receptor ligands 96
Pharmacological and Biochemical Characterization of Purified A2A Adenosine Receptors in Human Platelet Membranes by [3H]-CGS 21680 Binding 95
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 95
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 95
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding 95
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 95
null 93
Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H] SCH 58261 binding 92
Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour 92
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 92
null 92
null 91
Temperature dependence and GABA modulation of b-carboline binding to rat cerebellum benzodiazepine receptors. 90
Pharmacological, biochemical and thermodynamic characterization of purified adenosine A2A receptors in human platelet membranes by [3H] CGS 21680 binding 90
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 90
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 89
null 88
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 88
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. 87
Binding thermodynamics of serotonin to rat brain 5HT1A, 5HT2A and 5HT3 receptors 87
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 86
Odorants could elicit repair processes in melanized neuronal and skin cells 85
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 85
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 83
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 83
null 83
null 83
Nasal administration and brain targeting of an antiischemic agent 81
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 81
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 81
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 81
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 81
null 81
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 80
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 79
null 79
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 79
null 77
null 76
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 76
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 76
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 75
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 75
Nasal administration of micropspheres containing a new antiamoebic drug 74
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 74
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 73
Totale 10.206
Categoria #
all - tutte 70.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.629
Totale 71.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.833 0 122 125 494 207 391 270 374 244 399 129 78
2020/20212.762 221 314 186 253 94 272 80 297 106 445 364 130
2021/20221.971 50 228 148 120 87 85 77 102 76 163 180 655
2022/20232.003 228 99 53 261 383 312 60 158 250 15 118 66
2023/20241.009 120 135 60 25 95 116 35 39 15 21 33 315
2024/2025184 100 84 0 0 0 0 0 0 0 0 0 0
Totale 16.517